change the use of anticoagulant therapy for venous thromboembolism (VTE)

October 2008

New Chest guidelines will change the use of anticoagulant therapy for venous thromboembolism (VTE).

Initial treatment. Prescribe low-molecular-weight heparins (LMWH) as the standard initial treatment for most patients.

But consider SC unfractionated heparin, IV unfractionated heparin, or fondaparinux (Arixtra) as alternatives.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: MD includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote